Species | Potential target | Raw | Global | Species |
---|---|---|---|---|
Trichomonas vaginalis | PIKK family atypical protein kinase | 0.0208 | 0.0316 | 1 |
Echinococcus multilocularis | DNA dependent protein kinase catalytic subunit | 0.2981 | 1 | 1 |
Trichomonas vaginalis | PIKK family atypical protein kinase | 0.0208 | 0.0316 | 1 |
Trichomonas vaginalis | PIKK family atypical protein kinase | 0.0208 | 0.0316 | 1 |
Giardia lamblia | GTOR | 0.0208 | 0.0316 | 0.5 |
Loa Loa (eye worm) | hypothetical protein | 0.013 | 0.0047 | 0.1478 |
Leishmania major | hypothetical protein, conserved | 0.1082 | 0.3371 | 1 |
Trichomonas vaginalis | PIKK family atypical protein kinase | 0.0208 | 0.0316 | 1 |
Trichomonas vaginalis | PIKK family atypical protein kinase | 0.0208 | 0.0316 | 1 |
Trichomonas vaginalis | PIKK family atypical protein kinase | 0.0208 | 0.0316 | 1 |
Entamoeba histolytica | FKBP-rapamycin associated protein (FRAP), putative | 0.0208 | 0.0316 | 1 |
Trichomonas vaginalis | PIKK family atypical protein kinase | 0.0208 | 0.0316 | 1 |
Schistosoma mansoni | phosphatidylinositol 3-and 4-kinase | 0.0208 | 0.0316 | 1 |
Toxoplasma gondii | non-specific serine/threonine protein kinase | 0.013 | 0.0047 | 0.1478 |
Trichomonas vaginalis | PIKK family atypical protein kinase | 0.0208 | 0.0316 | 1 |
Trypanosoma cruzi | phosphatidylinositol 3-related kinase, putative | 0.0208 | 0.0316 | 0.0978 |
Trypanosoma brucei | phosphatidylinositol 3-kinase, putative | 0.0208 | 0.0316 | 1 |
Trichomonas vaginalis | PIKK family atypical protein kinase | 0.0208 | 0.0316 | 1 |
Trichomonas vaginalis | PIKK family atypical protein kinase | 0.0208 | 0.0316 | 1 |
Echinococcus granulosus | phosphatidylinositol 3 and 4 kinase | 0.0208 | 0.0316 | 0.0316 |
Trichomonas vaginalis | PIKK family atypical protein kinase | 0.0208 | 0.0316 | 1 |
Trichomonas vaginalis | PIKK family atypical protein kinase | 0.0208 | 0.0316 | 1 |
Trichomonas vaginalis | PIKK family atypical protein kinase | 0.0208 | 0.0316 | 1 |
Trichomonas vaginalis | PIKK family atypical protein kinase | 0.0208 | 0.0316 | 1 |
Brugia malayi | Phosphatidylinositol 3- and 4-kinase family protein | 0.0208 | 0.0316 | 1 |
Brugia malayi | Phosphatidylinositol 3- and 4-kinase family protein | 0.0208 | 0.0316 | 1 |
Entamoeba histolytica | phosphatidylinositol3-kinaseTor2, putative | 0.0208 | 0.0316 | 1 |
Loa Loa (eye worm) | phosphatidylinositol 3 | 0.0208 | 0.0316 | 1 |
Trypanosoma brucei | phosphatidylinositol 3-related kinase, putative | 0.0208 | 0.0316 | 1 |
Echinococcus multilocularis | FKBP12 rapamycin complex associated protein | 0.0208 | 0.0316 | 0.0316 |
Trichomonas vaginalis | PIKK family atypical protein kinase | 0.013 | 0.0047 | 0.1478 |
Echinococcus granulosus | FKBP12 rapamycin complex associated protein | 0.0208 | 0.0316 | 0.0316 |
Trichomonas vaginalis | PIKK family atypical protein kinase | 0.0208 | 0.0316 | 1 |
Trichomonas vaginalis | PIKK family atypical protein kinase | 0.0208 | 0.0316 | 1 |
Trypanosoma cruzi | phosphatidylinositol 3-related kinase, putative | 0.0208 | 0.0316 | 0.0978 |
Toxoplasma gondii | target of rapamycin (TOR), putative | 0.0208 | 0.0316 | 1 |
Trichomonas vaginalis | PIKK family atypical protein kinase | 0.0208 | 0.0316 | 1 |
Trypanosoma cruzi | Phosphatidylinositol 3-kinase tor2 | 0.0208 | 0.0316 | 0.0978 |
Trichomonas vaginalis | conserved hypothetical protein | 0.013 | 0.0047 | 0.1478 |
Trichomonas vaginalis | PIKK family atypical protein kinase | 0.0208 | 0.0316 | 1 |
Trichomonas vaginalis | PIKK family atypical protein kinase | 0.0208 | 0.0316 | 1 |
Trichomonas vaginalis | PIKK family atypical protein kinase | 0.0208 | 0.0316 | 1 |
Trichomonas vaginalis | PIKK family atypical protein kinase | 0.0208 | 0.0316 | 1 |
Trichomonas vaginalis | PIKK family atypical protein kinase | 0.0208 | 0.0316 | 1 |
Trypanosoma cruzi | Phosphatidylinositol 3-kinase tor1 | 0.0208 | 0.0316 | 0.0978 |
Trichomonas vaginalis | PIKK family atypical protein kinase | 0.0208 | 0.0316 | 1 |
Trypanosoma brucei | phosphatidylinositol 4-kinase, putative | 0.0208 | 0.0316 | 1 |
Trichomonas vaginalis | PIKK family atypical protein kinase | 0.0208 | 0.0316 | 1 |
Schistosoma mansoni | ataxia telangiectasia mutated (atm)-related | 0.0208 | 0.0316 | 1 |
Trypanosoma brucei | FAT domain/Rapamycin binding domain/Phosphatidylinositol 3- and 4-kinase, putative | 0.013 | 0.0047 | 0.1478 |
Trichomonas vaginalis | PIKK family atypical protein kinase | 0.0208 | 0.0316 | 1 |
Trypanosoma brucei | Phosphatidylinositol 3-kinase tor1 | 0.0208 | 0.0316 | 1 |
Echinococcus multilocularis | phosphatidylinositol 3 and 4 kinase | 0.0208 | 0.0316 | 0.0316 |
Trichomonas vaginalis | PIKK family atypical protein kinase | 0.0208 | 0.0316 | 1 |
Loa Loa (eye worm) | phosphatidylinositol 3 | 0.0208 | 0.0316 | 1 |
Trichomonas vaginalis | PIKK family atypical protein kinase | 0.0208 | 0.0316 | 1 |
Trypanosoma brucei | target of rapamycin kinase 3, putative | 0.0208 | 0.0316 | 1 |
Trypanosoma cruzi | target of rapamycin kinase 3 | 0.0208 | 0.0316 | 0.0978 |
Trichomonas vaginalis | PIKK family atypical protein kinase | 0.0208 | 0.0316 | 1 |
Trichomonas vaginalis | PIKK family atypical protein kinase | 0.0208 | 0.0316 | 1 |
Trypanosoma cruzi | hypothetical protein, conserved | 0.1043 | 0.3232 | 1 |
Activity type | Activity value | Assay description | Source | Reference |
---|---|---|---|---|
MIC (functional) | <= 0.12 ug ml-1 | In vitro minimum inhibitory concentration of the compound against Streptococcus species; =0.12-0.5 | ChEMBL. | 12873519 |
MIC (functional) | = 1 ug ml-1 | In vitro minimum inhibitory concentration of the compound against Staphylococcus aureus; 1-4 | ChEMBL. | 12873519 |
MIC (functional) | = 2 ug ml-1 | In vitro minimum inhibitory concentration of the compound against Enterococcus species; 2-16 | ChEMBL. | 12873519 |
Many chemical entities in TDR Targets come from high-throughput screenings with whole cells or tissue samples, and not all assayed compounds have been tested against a single a single target protein, probably because they get ruled out during screening process. Even if these compounds may have not been of interest in the original screening, they may come as interesting leads for other screening assays. Furthermore, we may be able to propose drug-target associations using chemical similarities and network patterns.
1 literature reference was collected for this gene.